Csequence Insights

Stay Informed and Educated with Csequence’s Blog

"
"
Policy makers and the public at odds. Implementing legalization here and abroad. Perspectives on clinical research.

Policy makers and the public at odds. Implementing legalization here and abroad. Perspectives on clinical research.

More signals that DC policy makers are out of sync with the public, as the House wrangles the marijuana banking bill. The state of Massachusetts deals with the reality of legalization and so does Germany. One study shows that marijuana use doesn’t pose a significant risk in organ donation and another suggests significant increased risk of heart attack and stroke among marijuana consumers. Once again highlighting the need for more clinical research on cannabis. The FDA offers perspective.

read more
Unveiling the Shadows: Cannabis-Induced Psychosis and the Rising Concerns 

Unveiling the Shadows: Cannabis-Induced Psychosis and the Rising Concerns 

This article is crucial as it sheds light on the increasingly common yet often overlooked risk of cannabis-induced psychosis, exemplified by the alarming case of Bryn Spejcher. By presenting scientific evidence and real-life incidents, it underscores the need for informed discussions and heightened awareness about the potential mental health consequences associated with marijuana use, particularly in the context of the evolving landscape of cannabis legalization. 

read more
Navigating the Waves of Cannabis Legalization: Impact on Hospitalizations in Canada

Navigating the Waves of Cannabis Legalization: Impact on Hospitalizations in Canada

This study is important because it helps us understand what happened to hospitalizations when Canada made nonmedical cannabis legal. It shows that while there was initially a decrease in hospitalizations right after the law changed, later on, when more cannabis was available, there was an increase in health issues related to cannabis.

read more
A Look Back, and Ahead. Scientists, Doctors, and Democrats Speak Up.

A Look Back, and Ahead. Scientists, Doctors, and Democrats Speak Up.

This week a look back at 2023 cannabis market and predictions for 2024. Scientists develop new testing methods ahead of federal standards for legal driving limits. The AMA says safe drug consumption sites save lives. Frequent use of cannabis could increase the risk of developing asthma. And 12 Democrats, including Senate Majority Leader Schumer, apply pressure to the DEA’s decision on moving marijuana from Schedule I to Schedule III of the Controlled Substances Act.

read more
Fed and States Grapple with Implementation. Relaxed Cannabis Restrictions in Sports.

Fed and States Grapple with Implementation. Relaxed Cannabis Restrictions in Sports.

Minnesota began a pilot program to test drivers for cannabis and other substances. Washington state ponders the science behind brain development and cannabis use. The Congressional Research Service published a report this week on legal consequence of rescheduling marijuana. Both the NCAA and Ultimate Fighting Championship have officially removed marijuana from it’s banned substances list. Meanwhile, the NFL is helping to fund a study on the benefits of CBD.

read more